Ligand recognition and activation of neuromedin U receptor 2

Neuromedin U receptor 2 (NMU2), an emerging attractive target for treating obesity, has shown the capability in reducing food intake and regulating energy metabolism when activated. However, drug development of NMU2 was deferred partially due to the lack of structural information. Here, we present t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wenli, Zhang, Wenru, Wang, Mu, Lu, Minmin, Chen, Shutian, Tang, Tingting, Schnapp, Gisela, Wagner, Holger, Brennauer, Albert, Yi, Cuiying, Chu, Xiaojing, Han, Shuo, Wu, Beili, Zhao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794833/
https://www.ncbi.nlm.nih.gov/pubmed/36575163
http://dx.doi.org/10.1038/s41467-022-34814-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794833/
https://www.ncbi.nlm.nih.gov/pubmed/36575163
http://dx.doi.org/10.1038/s41467-022-34814-4

Ejemplares similares